BIO4 Campus joined BioTechX Europe in Basel, one of the leading global conferences at the intersection of artificial intelligence, digital health, and pharmaceutical innovation.

The event brought together major pharmaceutical companies, technology leaders, and research institutions driving advances in AI-powered drug discovery, digital twins, data-driven R&D, and computational approaches to therapeutic development. Sessions explored how machine learning, predictive modeling, and large-scale data integration are reshaping the pharmaceutical pipeline — from target identification to clinical trial design.

Positioning BIO4 in the AI-biotech landscape

Through targeted meetings and exchanges, BIO4 Campus strengthened international connections and reinforced its positioning as a platform for computational biology and AI-driven biotech collaboration in Southeast Europe. The participation highlighted BIO4's focus on bioinformatics and artificial intelligence as core pillars of its strategic development, aligning with global trends in digital transformation of life sciences.

As the pharmaceutical industry increasingly relies on computational tools and interdisciplinary expertise, BIO4's engagement at BioTechX Europe underscored the ecosystem's readiness to contribute to — and learn from — the next generation of drug discovery innovation.